Company: INDP
Filing Date: 2025-09-02
Form Type: 424B5
Source: 0001493152-25-012530
Chunk: 64

Company: Indaptus Therapeutics, Inc.
Filing Date: 2025-09-02
Form: 424B5
Chunk 64
---
 The information incorporated by reference is deemed to be part of this prospectus, and subsequent information that we file with the SEC will automatically update and supersede that information. Any statement contained in this prospectus or a previously filed document incorporated by reference will be deemed to be modified or superseded for purposes of this prospectus to the extent that a statement contained in this prospectus or a subsequently filed document incorporated by reference modifies or replaces that statement.

This prospectus and any accompanying prospectus supplement incorporate by reference the documents set forth below that have previously been filed with the SEC:

| ● 
 ● | our Annual Report on Form 10-K for the year ended December 31, 2024 (filed with the SEC on March 13, 2025);                          
 our                                                                                                                                  
 Quarterly Reports on Form 10-Q for the quarters ended March 31, 2025 (filed with the SEC on May                                      
 14, 2025) and June 30, 2025 (filed with the SEC on August                                                                            
 13, 2025);                                                                                                                           |
|:--|:-------------------------------------------------------------------------------------------------------------------------------------|
| ● | our Current Reports on                                                                                                               
 Form 8-K (other than portions thereof furnished under Item 2.02 or Item 7.01 of Form 8-K and exhibits accompanying such reports that 
 relate to such items) filed with the SEC on January 14, 2025, January 31, 2025, February 12, 2025, March 13, 2025, May 14, 2025,     
 June 11, 2025, June 13, 2025, June 26, 2025, July 1, 2025, July 16, 2025 and July 29, 2025;                                          |
| ● | our annual Proxy Statement                                                                                                           
 on Schedule 14A relating to our annual meeting of stockholders, filed on April 28, 2025 (with respect to those portions incorporated 
 by reference into our Annual Report on Form 10-K for the year ended December 31, 2024).                                              |
| ● | the description of our                                                                                                               
 shares of common stock contained in Item 1 of the Registration Statement on Form 8-A (File No. 001-40652), filed with the SEC on     
 July 23, 2021, including any amendment or report filed for the purpose of updating such description.                                 |

We are not,